Current Medicinal Chemistry
Title: Preface
Volume: 7 Issue: 9
Author(s): Annette Beck Sickinger
Affiliation:
Export Options
About this article
Cite this article as:
Sickinger Beck Annette, Preface, Current Medicinal Chemistry 2000; 7 (9) . https://dx.doi.org/10.2174/0929867003374471
DOI https://dx.doi.org/10.2174/0929867003374471 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
17
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Current Trends and Future Strategies for the Global Impact of COVID-19 Pandemic
Coronaviruses Identification of Inflammatory, Metabolic, and Cell Survival Pathways Contributing to Cerebral Small Vessel Disease by Postmortem Gene Expression Microarray
Current Neurovascular Research Repertoire of Gluten Peptides Active in Celiac Disease Patients: Perspectives For Translational Therapeutic Applications
Endocrine, Metabolic & Immune Disorders - Drug Targets Recent Progress in Cerebrovascular Gene Therapy
Current Neurovascular Research subject Index To Volume 1
Current Medicinal Chemistry - Central Nervous System Agents Mitochondria: the Headquarters in Ischemia-Induced Neuronal Death
Central Nervous System Agents in Medicinal Chemistry Editorial from Editor-in-Chief
Inflammation & Allergy - Drug Targets (Discontinued) Meet Our Editorial Board Member
CNS & Neurological Disorders - Drug Targets The Evaluation and Management of Adult-Onset Henoch-Schonlein Purpura
Current Rheumatology Reviews Molecular, Cellular, and Epigenetic Signatures of Prostaglandin E2 in Endometriosis
Current Women`s Health Reviews Effects of ACE-Inhibitors and Angiotensin Receptor Blockers on Inflammation
Current Pharmaceutical Design Regioselective Synthesis of Potent 4,5,6,7-Tetrahydroindazole Derivatives via Microwave-assisted Vilsmeier-Haack Reaction and their Antioxidant Activity Evaluation
Letters in Organic Chemistry A Fresh Prospect of Extracellular Matrix Hydrolytic Enzymes and Their Substrates
Current Pharmaceutical Design Resistance to Macrocyclic Lactones
Current Pharmaceutical Biotechnology Circulating Biomarkers for the Diagnosis and Prognosis of Heart Failure
Current Medicinal Chemistry Signal Transducer and Activator of Transcription 3 Signaling Pathway: A Potential Target in Sarcoma Treatment
Current Enzyme Inhibition A Computational View of COX-2 Inhibition
Anti-Cancer Agents in Medicinal Chemistry KIR Molecules: Recent Patents of Interest for the Diagnosis and Treatment of Several Autoimmune Diseases, Chronic Inflammation, and B-cell Malignancies
Recent Patents on DNA & Gene Sequences Alzheimers Disease (AD) and Mild Cognitive Impairment (MCI) Patients are Characterized by Increased BDNF Serum Levels
Current Alzheimer Research Inhibition of Long Non-coding RNA CTD-2574D22.4 Alleviates LPS-induced Apoptosis and Inflammatory Injury of Chondrocytes
Current Pharmaceutical Design